T1	Outcomes 741 754	flow cytometr
T2	Outcomes 787 806	computed tomography
T3	Outcomes 837 864	tumor recurrent conditions.
T4	Outcomes 895 965	percentages of CD3+, CD4+, CD56+, CD3+CD56+ cells, and CD4+/CD8+ ratio
T5	Outcomes 1152 1175	percentage of CD8 cells
T6	Outcomes 1232 1268	1-year and 18-month recurrence rates